Zakharova Faina M, Damgaard Dorte, Mandelshtam Michail Y, Golubkov Valery I, Nissen Peter H, Nilsen Gitte G, Stenderup Anette, Lipovetsky Boris M, Konstantinov Vladimir O, Denisenko Alexander D, Vasilyev Vadim B, Faergeman Ole
Department of Molecular Genetics, Institute of Experimental Medicine, St-Petersburg, Russia.
BMC Med Genet. 2005 Feb 8;6:6. doi: 10.1186/1471-2350-6-6.
Familial hypercholesterolemia is a human monogenic disease caused by population-specific mutations in the low density lipoprotein (LDL) receptor gene. Despite thirteen different mutations of the LDL receptor gene were reported from Russia prior to 2003, the whole spectrum of disease-causing gene alterations in this country is poorly known and requires further investigation provided by the current study.
Forty-five patients with clinical diagnosis of FH were tested for the apolipoprotein B (apoB) mutation R3500Q by restriction fragment length analysis. After exclusion of R3500Q mutation high-sensitive fluorescent single-strand conformation polymorphism (SSCP) analysis and automatic DNA sequencing were used to search for mutations in the LDL receptor gene.
We found twenty one rare sequence variations of the LDL receptor gene. Nineteen were probably pathogenic mutations, and two (P518P, T705I) were considered as neutral ones. Among the mutations likely to be pathogenic, eight were novel (c.670-671insG, C249X, c.936-940del5, c.1291-1331del41, W422X, c.1855-1856insA, D601N, C646S), and eleven (Q12X, IVS3+1G>A, c.651-653del3, E207X, c.925-931del7, C308Y, L380H, c.1302delG, IVS9+1G>A, V776M, V806I) have already been described in other populations. None of the patients had the R3500Q mutation in the apoB gene.
Nineteen pathogenic mutations in the LDL receptor gene in 23 probands were identified. Two mutations c.925-931del7 and L380H are shared by St.-Petersburg population with neighbouring Finland and several other mutations with Norway, Sweden or Denmark, i.e. countries from the Baltic Sea region. Only four mutations (c.313+1G>A, c.651-653del3, C308Y and W422X) were recurrent as all those were found in two unrelated families. By this study the number of known mutations in the LDL receptor gene in St.-Petersburg area was increased nearly threefold. Analysis of all 34 low density lipoprotein receptor gene mutations found in St.-Petersburg argues against strong founder effect in Russian familial hypercholesterolemia.
家族性高胆固醇血症是一种人类单基因疾病,由低密度脂蛋白(LDL)受体基因中特定人群的突变引起。尽管在2003年之前俄罗斯已报告了13种LDL受体基因的不同突变,但该国致病基因改变的全貌仍知之甚少,需要本研究进一步探究。
对45例临床诊断为FH的患者进行载脂蛋白B(apoB)突变R3500Q的限制性片段长度分析。排除R3500Q突变后,采用高灵敏度荧光单链构象多态性(SSCP)分析和自动DNA测序来寻找LDL受体基因中的突变。
我们发现了21种LDL受体基因的罕见序列变异。其中19种可能是致病突变,2种(P518P、T705I)被认为是中性变异。在可能致病的突变中,8种是新发现的(c.670 - 671insG、C249X、c.936 - 940del5、c.1291 - 1331del41、W422X、c.1855 - 1856insA、D601N、C646S),11种(Q12X、IVS3 + 1G>A、c.651 - 653del3、E207X、c.925 - 931del7、C308Y、L380H、c.1302delG、IVS9 + 1G>A、V776M、V806I)已在其他人群中被描述。所有患者的apoB基因均未发生R3500Q突变。
在23名先证者中鉴定出LDL受体基因的19种致病突变。圣彼得堡人群与邻国芬兰共有两种突变c.925 - 931del7和L380H,与挪威、瑞典或丹麦(即波罗的海地区国家)共有其他几种突变。只有4种突变(c.313 + 1G>A、c.651 - 653del3、C308Y和W422X)是重复出现的,因为这些突变均在两个不相关的家族中被发现。通过本研究,圣彼得堡地区已知的LDL受体基因中的突变数量增加了近三倍。对在圣彼得堡发现的所有34种低密度脂蛋白受体基因突变的分析表明,俄罗斯家族性高胆固醇血症不存在强烈的奠基者效应。